Table 2 |
|||
| Univariate analysis for determinants of survival after hepatectomy | |||
| Variable | Nonsurvivors/survivors | OR(95%CI) | P(a) |
| n (%)or median(IQR) | n =13 n =57 | ||
| Type of hepatectomy surgery | 0.105 (b) | ||
| for malignant disease | 13 (100) / 45 (78) | – | |
| for benign disease | 0 (0) /12 (21) | 1 | |
| Age | 65 (54 – 71) / 57 (44 – 66) | 1.04 (0.99 – 1.10) | 0.109 |
| Gender | 0.759 | ||
| Female | 6 (46) / 29 (51) | 1 | |
| Male | 7 (54) / 28 (49) | 0.83 (0.25 – 2.77) | |
| BMI, median | 25 (22 – 31) /25 (22 – 29) | 0.99 (0.88 – 1.13) | 0.981 |
| Type of anesthesia | 0.424 | ||
| General | 10 (77) /49 (86) | 1 | |
| Combined general loco regional | 3 (23) / 8 (14) | 1.84 (0.41 – 8.16) | |
| Duration of anesthesia (minutes) | 300 (255 – 395) / 300 (265–330) | 1.01 (0.99 – 1.01) | 0.161 |
| ASA Physical status | 0.443 (b) | ||
| I/II | 0 (0) /23 (40) | 1 | |
| III/IV | 13 (100) / 34 (60) | – | |
| Intraoperative fluid volume, median | |||
| Crystalloids (L.) | 4.2 (4.0– 5.0) / 4.0 (3.1 – 4.9) | 1.26 (0.86 – 1.87) | 0.239 |
| Colloids (L.) | 0.5 (0–1.0) / 0.5 (0 – 0.5) | 1.39 (0.34 – 5.79) | 0.649 |
| Erythrocytes(Unit) | 1(0 – 3.0) /0(0–1) | 2.92(1.25–6.81) | 0.013 |
| Fresh Frozen plasma (Unit) | 0 (0 – 0) / 0 (0 – 0) | 1.44 (0.80 – 2.58) | 0.221 |
| Platelets (Unit) | 0 (0 – 0) / 0 (0 – 0) | – | 1 |
| Temperature at admission | 34.2 (33.3 – 35.1) / 35.0 (33.9 – 35.6) | 0.72 (0.44 – 1.17) | 0.184 |
| Hypertension | 8 (62) / 29 (51) | 1.55 (0.45 – 5.30) | 0.489 |
| Hyperlipidaemia | 7 (54) / 18 (32) | 2.53 (0.74 – 8.61) | 0.138 |
| Pulmonary obstructive disease | 2 (15) / 6 (11) | 1.55 (0.28 – 8.70) | 0.621 |
| Ischemic heart disease | 3 (23) / 3 (5) | 5.40 (0.95 – 30.7) | 0.057 |
| Congestive heart disease | 3 (23) / 7 (12) | 2.14 (0.47 – 9.73) | 0.324 |
| Cerebrovascular disease | 2 (15) /1 (2) | 10.18 (0.85 – 122) | 0.067 |
| Insulin therapy for diabetes | 2 (15) / 1 (2) | 10.18 (0.85 – 122) | 0.067 |
| Renal insufficiency | 1 (8) / 3 (5) | 1.50 (0.14 – 15.7) | 0.735 |
| RCRI | 0.019 | ||
| ≤2 | 10 (77)/56(98) | 1 | |
| >2 | 3(23) / 1(2) | 16.8(1.59–178) | |
| Delirium | 9 (69) /8(14) | 13.78(3.42–55.60) | <0.001 |
| Previous score in Katz scale | 0 (0 – 0) / 0 (0 – 0) | – | 1 |
| Previous score in Lawton scale | 7 (7 – 7) / 7 (7 – 7) | – | 1 |
| SAPS II,median | 32.0(23.5–48.0) / 24.0(13.0–33.5) | 1.07(1.02–1.12) | 0.011 |
| APACHE II | 12.0(10.5–16.0) /7.0 (4.0–9.0) | 1.55(1.21–1.98) | <0.001 |
| Length of PACU stay (hours) | 20 (18 – 80) / 21 (19 – 50) | 1.01 (0.99 – 1.03) | 0.276 |
| Length of Hospital stay (days) | 14 (7 – 17) / 10 (7 – 13) | 1.00 (0.95 – 1.06) | 0.906 |
IQR, Interquartil range; OR, Odds Ratio; CI, Confidence Interval.
a) P value (binary logistic regression); b) Fisher’s exact test.
BMI, Body mass index; ASA, American Society of anesthesiologists; RCRI, Revised cardiac risk index; PACU, Post Anesthesia Care Unit; SAPS, Simplified Acute Physiology Score; APACHE II Acute Physiology & Chronic Health Evaluation.
Veiga et al. BMC Anesthesiology 2013 13:4 doi:10.1186/1471-2253-13-4
